Cargando…
Treatment of Homozygous Type II Antithrombin Heparin-Binding Site Deficiency in Pregnancy
Pregnancy is associated with an increased risk of venous thromboembolism (VTE). Previous VTE and severe thrombophilia are important risk factors. Our case was a 36-year-old woman, gravida 6, para 0, with antithrombin (AT) deficiency caused by a homozygous mutation in the heparin-binding site (HBS)....
Autores principales: | Fiskvik, Hilde, Jacobsen, Anne F., Iversen, Nina, Henriksson, Carola E., Jacobsen, Eva-Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433018/ https://www.ncbi.nlm.nih.gov/pubmed/34513101 http://dx.doi.org/10.1155/2021/4393821 |
Ejemplares similares
-
Thrombin Decrease in Thrombin Generation after Heparin Administration in a Homozygous Type II Heparin-Binding Site Antithrombin-Deficient Pregnant Woman
por: Malíková, Ivana, et al.
Publicado: (2023) -
Comparison of antithrombin activity assays in detection of patients with heparin binding site antithrombin deficiency: systematic review and meta-analysis
por: Rojnik, Tamara, et al.
Publicado: (2023) -
Heparanase Activates Antithrombin through the Binding to Its Heparin Binding Site
por: Bohdan, Nataliya, et al.
Publicado: (2016) -
On the Specificity of Heparin/Heparan Sulfate Binding to Proteins. Anion-Binding Sites on Antithrombin and Thrombin Are Fundamentally Different
por: Mosier, Philip D., et al.
Publicado: (2012) -
Investigation of the Differences in Antithrombin to Heparin Binding among Antithrombin Budapest 3, Basel, and Padua Mutations by Biochemical and In Silico Methods
por: Gindele, Réka, et al.
Publicado: (2021)